Internal Medicine, Infectious Disease · Las Vegas, NV
NPI
1598889008
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
701 Shadow Lane # 200
Las Vegas, NV, 89106
Phone (702) 383-2691
Groups this clinician bills Medicare through
Medicare paid, 2024
$733K
6,030 services
Medicare patients, 2024
143
Average age 64
Drug cost, 2024
$10.2M
4,050 prescriptions
Company payments, 2025
$106K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alireza Farabi was code 96366 (intravenous infusion, hydration), 517 times for 11 patients. In total Alireza Farabi billed 6,030 services in 22 codes, and Medicare paid $733K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96366 Intravenous Infusion, Hydration | Office | 517 | 11 | $15.28 | $7,894 |
| 99214 Office E&M - Established | Office | 297 | 91 | $94.03 | $28K |
| 96365 Intravenous Infusion, Hydration | Office | 218 | 13 | $47.20 | $10K |
| 96372 Injection Administration | Office | 83 | 16 | $10.89 | $904 |
| 99205 Office E&M - New | Office | 39 | 39 | $146.24 | $5,703 |
| 99213 Office E&M - Established | Office | 29 | 21 | $70.72 | $2,051 |
| 99222 Hospital E&M - Initial | Facility | 21 | 20 | $100.01 | $2,100 |
| 46607 Digestive/Gastrointestinal | Office | 16 | 15 | $160.14 | $2,562 |
| 46601 Digestive/Gastrointestinal | Office | 13 | 11 | $113.31 | $1,473 |
By year: 2022 $1.2M for 15,217 services; 2023 $777K for 7,784 services; 2024 $733K for 6,030 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alireza Farabi prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 902 prescriptions and refills. In total Alireza Farabi wrote 4,050 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 902 | 902 | 147 | $3.7M |
| Dovato Dolutegravir Sodium/Lamivudine | 413 | 413 | 62 | $1.2M |
| Tivicay Dolutegravir Sodium | 295 | 297 | 52 | $696K |
| Cabenuva Cabotegravir/Rilpivirine | 240 | 332 | 51 | $1.6M |
| Juluca Dolutegravir/Rilpivirine | 181 | 183 | 31 | $654K |
| Atorvastatin Calcium Generic | 141 | 158 | 32 | $672 |
| Pifeltro Doravirine | 131 | 143 | 24 | $255K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 127 | 127 | 24 | $603K |
| Prezcobix Darunavir/Cobicistat | 100 | 102 | 17 | $249K |
| Metformin Hcl Er Metformin Hcl | 79 | 97 | 15 | $252 |
| Vascepa Icosapent Ethyl | 71 | 75 | 15 | $26K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 56 | 56 | Under 11 | $216K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 52 | 58 | 11 | $450 |
| Lisinopril Generic | 48 | 62 | Under 11 | $163 |
| Descovy Emtricitabine/Tenofov Alafenam | 47 | 47 | 11 | $107K |
Brand drugs: 2,844 claims; generic drugs: 1,206 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alireza Farabi $106K ($106K in general payments such as food, travel and fees) from 8 companies. The largest payer was ViiV Healthcare Company with $67K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.